QICCD 2020: Diagnosis and Treatment of Cardiovascular Disease
Dr. Kunlin Cao, President of Keya Medical R&D, participated in the Cardiovascular Disease Imaging Forum at QICCD 2020 alongside Dr. Pengfei Zhang of Shangdong University.
Keya Medical Presents at the Second Congress of China AI in Medical Imaging Conference
Dr. Kunlin Cao delivered a keynote address at the China AI in Medical Imaging Conference on Keya Medical’s experience bringing AI-powered medical imaging solutions to clinical use.
Innovation Fast and Slow: The Case for Coronary CT Angiography
Recent research demonstrates applications for CCTA to be used as the default test for evaluating patients with stable chest pain.
Keya Medical Wins 2020 Ernst & Young Fudan China’s Most Promising Company Award
On Sept. 18, Keya Medical was recognized as the winner of of China’s Most Promising Company award because of its leading R&D team and innovative cardiovascular product line.
DEEPVESSEL FFR Service Workflow
The DEEPVESSEL FFR Analysis platform securely processes coronary CTA data provided by health systems.
Recent Comments